UK Government Explores Weight-Loss Drugs to Boost Workforce Participation

Mon Dec 23 2024 16:21:45 GMT+0200 (Eastern European Standard Time)
UK Government Explores Weight-Loss Drugs to Boost Workforce Participation

The British government partners with Eli Lilly for a trial assessing tirzepatide's effects on obesity and productivity.


A new UK government initiative will study how the weight-loss drug tirzepatide could affect obesity and workplace productivity, aiming to enhance economic performance.

On Monday, the UK government announced a major partnership with pharmaceutical company Eli Lilly, focusing on the effects of a weight-loss drug, tirzepatide, also known as Mounjaro. This five-year initiative aims to assess the drug's impact on obesity, diabetes prevention, and productivity in the workplace. With obesity costing the National Health Service billions annually and stunting productivity, the trial will occur in Greater Manchester, studying up to 3,000 participants' health, employment status, and sick leave. This $365 million venture highlights the potential of health interventions in addressing broader economic issues. Prime Minister Keir Starmer emphasized the drug's importance in improving health and aiding people back to work, thus benefiting the economy. This initiative reflects a dual focus on enhancing public health and national productivity through innovative medical solutions.

MORE ON THEME

Fri, 20 Dec 2024 19:25:45 GMT

Salvini Acquitted: A Setback for Migrant Rights in Italy?

Fri, 20 Dec 2024 19:25:45 GMT
Fri, 20 Dec 2024 12:40:27 GMT

The Disturbing Duality of Dominique Pelicot: Exploring the Mind of a Convicted Rapist

Fri, 20 Dec 2024 12:40:27 GMT
Fri, 20 Dec 2024 11:53:37 GMT

Romanian Court Halts Andrew Tate's Criminal Case Progression

Fri, 20 Dec 2024 11:53:37 GMT
Fri, 20 Dec 2024 05:56:08 GMT

Verdict Looms for Eight Defendants in Samuel Paty Murder Case

Fri, 20 Dec 2024 05:56:08 GMT
Fri, 20 Dec 2024 00:56:47 GMT

**Court Ruling Awaits for Accused in Samuel Paty Murder Case**

Fri, 20 Dec 2024 00:56:47 GMT
Thu, 19 Dec 2024 21:37:38 GMT

The Pelicot Trial: A Landmark Case on Sexual Violence in France

Thu, 19 Dec 2024 21:37:38 GMT
Mon, 16 Dec 2024 03:40:15 GMT

A Harrowing Truth: Gisèle Pelicot's Nightmare of Betrayal and Abuse

Mon, 16 Dec 2024 03:40:15 GMT
Sun, 15 Dec 2024 00:23:51 GMT

From Love to Betrayal: The Tragic Journey of Gisèle Pelicot

Sun, 15 Dec 2024 00:23:51 GMT
Thu, 12 Dec 2024 05:06:01 GMT

French Actor Adèle Haenel Confronts Alleged Abuser in Trial

Thu, 12 Dec 2024 05:06:01 GMT
Wed, 11 Dec 2024 20:43:36 GMT

The Complexity of Collective Guilt: The Gisèle Pelicot Mass Rape Case

Wed, 11 Dec 2024 20:43:36 GMT
Wed, 11 Dec 2024 15:13:47 GMT

**Adèle Haenel Challenges Accused Director Amidst Legal Battle**

Wed, 11 Dec 2024 15:13:47 GMT
Wed, 11 Dec 2024 10:46:47 GMT

**Prince William and Trump: A Royal Connection Amidst Political Tensions**

Wed, 11 Dec 2024 10:46:47 GMT
Wed, 11 Dec 2024 07:23:59 GMT

The Monsieur-Tout-Le-Monde: A Collective Confrontation in the Gisèle Pelicot Rape Case

Wed, 11 Dec 2024 07:23:59 GMT
Sun, 08 Dec 2024 10:33:37 GMT

Exploring the Four-Day Workweek: British Companies Test Shorter Hours

Sun, 08 Dec 2024 10:33:37 GMT
Tue, 03 Dec 2024 00:28:14 GMT

Biden's Controversial Pardon for Hunter: A Closer Look

Tue, 03 Dec 2024 00:28:14 GMT
Tue, 26 Nov 2024 13:36:09 GMT

French Prosecutors Seek Maximum Sentence in Landmark Mass Rape Trial

Tue, 26 Nov 2024 13:36:09 GMT
Mon, 25 Nov 2024 21:11:57 GMT

Prosecutors Seek Maximum Sentence in Landmark French Mass Rape Case

Mon, 25 Nov 2024 21:11:57 GMT
Mon, 25 Nov 2024 07:04:28 GMT

**Family Saga Unraveled: A Trial of Betrayal and Trauma in the Pelicot Case**

Mon, 25 Nov 2024 07:04:28 GMT
Mon, 25 Nov 2024 06:27:54 GMT

The Unraveling of the Pelicot Family: A Tale of Betrayal and Suffering

Mon, 25 Nov 2024 06:27:54 GMT
Sun, 24 Nov 2024 11:12:36 GMT

South Korean Man Faces Consequences for Attempting to Avoid Military Service through Binge Eating

Sun, 24 Nov 2024 11:12:36 GMT

Follow us

© 2024 SwissX REDD UK ltd. All Rights Reserved.